This indicator measures the rate of public drug program spending on generic drugs.
This indicator is interpreted as the proportion of utilization that generic drug products account for within public drug programs.
Data availability:
to (calendar years)
Geographic coverage
Newfoundland and Labrador, Prince Edward Island, New Brunswick, Nova Scotia, Quebec, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Yukon
Reporting level
Province/Territory
Calculation
The total number of claims accepted by public drug programs for generic drugs divided by the total number of claims accepted by public drug programs
Unit of Analysis: Claims to public drug programs
Denominator
Total number of claims made to public drug programs
Numerator
Total number of claims made to public drug programs for a generic drug product
Comments
Not applicable